Wire Stories
581Kyriba’s Currency Impact Report Reveals North American and European Multinational Corporations Report $6.16 Billion in Total Quarterly FX Headwinds
SAN DIEGO–(BUSINESS WIRE)–Kyriba’s Currency Impact Report (CIR), a comprehensive report detailing the impacts of foreign exchange (FX) exposures among 1,200 multinational companies...
- 705
Wipro Achieves AWS Mainframe Migration Competency Status
NEW YORK & BANGALORE, India–(BUSINESS WIRE)–#APN–Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process...
- 637
Development of Chinese Telecoms in 5G Industrial Internet of Things, 2021 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Development of Chinese Telecoms in 5G Industrial Internet of Things” report has been added to ResearchAndMarkets.com’s offering. This report analyzes...
- 641
dotdigital partners with Adobe to power enhanced customer engagement across all touchpoints
LONDON–(BUSINESS WIRE)–Today, dotdigital, the leading marketing automation and customer engagement platform, announced the renewal of its status as a Premier Partner in...
- 734
Spectranetix Announces CMOSS TSM Solution for U.S. Army Capability Set 23
SUNNYVALE, Calif.–(BUSINESS WIRE)–#C4ISRNET–Spectranetix, Inc., a Pacific Defense company, is proud to announce that its industry-first integration of TrellisWare Technologies’ TSM™ software into...
- 609
Southeast Asia Data Center Market Outlook and Forecast 2021-2026 Featuring Key IT Infrastructure Providers, Support Infrastructure Providers, Contractors, Investors – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Data Center Market in Southeast Asia – Industry Outlook and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The...
- 591
Clinical Data Shows Noxopharm’s Veyonda® May Prevent Cytokine Storm
SYDNEY–(BUSINESS WIRE)–#Veyonda–Australian clinical-stage drug development company Noxopharm Limted (ASX:NOX) today announced that in a cohort of 18 patients with moderately severe cases...
- 612
Renesas Expands FemtoClock Timing Portfolio for High-Performance Communications and Data Center Applications
FemtoClock2 Family Simplifies Design with Industry’s Lowest Power and Smallest 75fs Jitter Clocks TOKYO–(BUSINESS WIRE)–#clock–Renesas Electronics Corporation (TSE:6723), a premier supplier of...
- 672
Revance Announces First Patient Enrolled for DaxibotulinumtoxinA in Glabellar Lines and Cervical Dystonia in China by Fosun Pharma
NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that Shanghai Fosun...
- 668
CANbridge Pharmaceuticals Announces Strategic Collaboration with LogicBio Therapeutics and Licenses to Gene Delivery and Editing Platforms
Worldwide License to AAV sL65 Capsid, Novel Liver-Targeting Capsid, to Support Development of CANbridge Gene Therapy Programs for Fabry disease, Pompe disease...
